Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-267,148
Closed -$14.4M 119
2023
Q2
$14.4M Buy
267,148
+1,309
+0.5% +$70.4K 0.24% 70
2023
Q1
$14.5M Buy
265,839
+68,851
+35% +$3.35M 0.26% 68
2022
Q4
$9.54M Buy
196,988
+119,765
+155% +$5.26M 0.19% 71
2022
Q3
$2.94M Buy
+77,223
New +$3.44M 0.05% 80

Other funds holding SNY

Samlyn Capital's SNY Position: Q3 2023 in Review

Samlyn Capital sold out of Sanofi (SNY) in Q3 2023, closing a stake of 267,148 shares — an estimated $14.4M sold.

Samlyn Capital first reported a position in SNY in Q3 2022 and held it in 4 quarters. The position peaked at $14.5M in Q1 2023. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

  • Samlyn Capital reported no remaining Sanofi position as of Q3 2023 after selling out during the quarter.
  • Samlyn Capital sold 267,148 Sanofi shares in Q3 2023, an estimated $14.4M.
  • Samlyn Capital first reported a position in Sanofi in Q3 2022 and held it in 4 quarters.
  • Samlyn Capital's Sanofi position peaked at $14.5M in Q1 2023.
  • 696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on Samlyn Capital's 13F filing for Q3 2023, filed 14 Nov 2023.